{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:41:53Z","timestamp":1793173313848,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejogrb.2017.01.025","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T14:16:56Z","timestamp":1484835416000},"page":"376-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The future for follow-up of gynaecological cancer in Europe. Summary of available data and overview of ongoing trials"],"prefix":"10.1016","volume":"210","author":[{"given":"S.C.","family":"Leeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Beaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.M.","family":"Ezendam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ma\u010duks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Martin-Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.01.025_bib0005","series-title":"Estimated cancer incidence, mortality and prevalence worldwide in 2012","author":"Globocan","year":"2012"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0010","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1600-0412.2012.01523.x","article-title":"Follow-up of gynaecological cancer patients after treatment \u2013 the views of European experts in gynecologic oncology","volume":"91","author":"Vistad","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jncimonographs\/lgq002","article-title":"The interface between primary and oncology specialty care: treatment through survivorship","volume":"40","author":"Grunfeld","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0020","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.3399\/bjgp09X453567","article-title":"Follow-up of cancer in primary care versus secondary care: systematic review","volume":"59","author":"Lewis","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/ijgc-00009577-200505000-00001","article-title":"The role of routine follow-up after gynecological malignancy","volume":"15","author":"Kew","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0030","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3399\/bjgp09X453576","article-title":"Patients' and healthcare professionals' views of cancer follow-up: systematic review","volume":"59","author":"Lewis","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/pon.2035","article-title":"Psychological treatment outcomes for cancer patients: what do meta-analyses tell us about distress reduction","volume":"21","author":"Linden","year":"2011","journal-title":"Psychooncology"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/pmj.79.933.403","article-title":"Patients' views on follow up of colorectal cancer: implications for risk communication and decision making","volume":"79","author":"Papagrigoriadis","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0045","doi-asserted-by":"crossref","first-page":"e002859","DOI":"10.1136\/bmjopen-2013-002859","article-title":"Gynaecological cancer follow-up: national survey of current practice in the UK","volume":"3","author":"Leeson","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0050","first-page":"CD006119","article-title":"Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment","volume":"6","author":"Kew","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/bjc.2012.554","article-title":"Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA","volume":"108","author":"Jefford","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0060","first-page":"223","article-title":"Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence","volume":"18","author":"Foster","year":"2009","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0065","doi-asserted-by":"crossref","first-page":"a3147","DOI":"10.1136\/bmj.a3147","article-title":"Comparing hospital and telephone follow-up after treatment for breast cancer: a randomised equivalence trial","volume":"338","author":"Beaver","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1463-1318.2012.02936.x","article-title":"An exploratory randomised controlled trial comparing telephone and hospital follow-up after treatment for colorectal cancer","volume":"14","author":"Beaver","year":"2012","journal-title":"Colorectal Dis"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.01.025_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2407-10-174","article-title":"Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer","volume":"2010","author":"Kimman","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0080","unstructured":"National Cancer Survivorship Initiative living with and beyond cancer: taking action to improve outcomes, https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/181054\/9333-TSO-2900664-NCSI_Report_FINAL.pdf; 2013 [Accessed 22.06.16]."},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/AOG.0000000000001129","article-title":"Recommendations for follow-up care for gynecologic cancer survivors","volume":"126","author":"Elit","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1479-828X.1995.tb01986.x","article-title":"Follow-up of patients with gynaecological cancer","volume":"35","author":"Kerr-Wilson","year":"1995","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/gyno.2000.5860","article-title":"Posttherapy surveillance of women with cervical cancer: an outcomes analysis","volume":"78","author":"Bodurka-Bevers","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3747\/co.v17i3.514","article-title":"Follow-up for women after treatment for cervical cancer","volume":"17","author":"Elit","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"MRC OV05; EORTC 55955 investigators. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1525-1438.2007.00943.x","article-title":"Follow-up strategies in gynaecological oncology: searching appropriateness","volume":"17","author":"Zola","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0115","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0125","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0130","first-page":"3483","article-title":"Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure","volume":"31","author":"Gadducci","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/gyno.1995.0012","article-title":"Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme","volume":"59","author":"Reddoch","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0140","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.1997.tb10979.x","article-title":"Recurrence of endometrial carcinoma and the value of routine follow up","volume":"104","author":"Salvesen","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/ijgc-00009577-200307000-00009","article-title":"Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study","volume":"13","author":"Sartori","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-8258(92)90134-5","article-title":"Detection and patterns of treatment failure in 300 consecutive cases of \u2018early\u2019 endometrial cancer after primary surgery","volume":"47","author":"Podczaski","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0155","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/IGC.0b013e3181e2abcc","article-title":"Surveillance procedures for patients treated for endometrial cancer: a review of the literature","volume":"20","author":"Sartori","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/gyno.1994.1282","article-title":"An evaluation of routine follow-up of patients treated for endometrial carcinoma","volume":"55","author":"Shumsky","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.01.025_bib0165","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Annals Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0170","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/IGC.0b013e31825ad3ee","article-title":"Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis","volume":"22","author":"Carrara","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0175","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10147-010-0080-7","article-title":"Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up","volume":"15","author":"Ueda","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0185","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1471-0528.1996.tb09843.x","article-title":"Is there any value in the long term follow up of women treated for endometrial cancer","volume":"103","author":"Owen","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","article-title":"Endometrial cancer: a review and current management strategies: part II","volume":"134","author":"SGO Clinical Practice Endometrial Cancer Study Group","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0195","article-title":"Comparing hospital and telephone follow-up for patients treated for Stage I endometrial cancer (ENDCAT Trial): a randomised, multicentre, non-inferiority trial","author":"Beaver","year":"2016","journal-title":"BJOG. Early view"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0200","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/497429","article-title":"Treatment for recurrent ovarian cancer at first relapse","volume":"2010","author":"Ushijima","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)","volume":"21","author":"Rustin","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0210","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/IGC.0000000000000218","article-title":"The role of HE4 in ovarian cancer follow-up: a review","volume":"24","author":"Piovano","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12885-015-1028-0","article-title":"Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance","volume":"15","author":"Brennan","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0220","series-title":"Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment (Review)","author":"Clarke","year":"2014"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/IGC.0000000000000877","article-title":"Ovarian cancer follow-up: a preliminary comparison of 2. approaches","volume":"27","author":"Lanceley","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0235","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IGC.0b013e3182611451","article-title":"Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study","volume":"22","author":"Geurts","year":"2012","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0240","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1471-0528.1996.tb09600.x","article-title":"Recurrent stage 1B cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance","volume":"10","author":"Ansink","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/gyno.1994.1140","article-title":"Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy","volume":"53","author":"Gerdin","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0936-6555(05)81037-4","article-title":"The value of follow-up in stage II carcinoma of the cervix","volume":"3","author":"Kunkler","year":"1991","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0255","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1471-0528.2004.00280.x","article-title":"The role of clinical follow up in early stage cervical cancer in South Wales","volume":"111","author":"Lim","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0260","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of Gynecologic Oncologist recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0265","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ygyno.2009.06.001","article-title":"Follow-up for women after treatment for cervical cancer: a systematic review","volume":"114","author":"Elit","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17120","article-title":"Positron emission tomography\/computerized tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling","volume":"17","author":"Meads","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0275","first-page":"11","article-title":"Follow-up protocols for women with cervical cancer after primary treatment","author":"Lanceley","year":"2013","journal-title":"Cochrane Database of Syst Rev."},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0280","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/bjs.6753","article-title":"Economic evaluation of a randomised clinical trial of hospital versus telephone follow-up after treatment for breast cancer","volume":"96","author":"Beaver","year":"2009","journal-title":"Br J Surgery"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0285","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ejca.2010.12.017","article-title":"Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT","volume":"47","author":"Kimman","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2017.01.025_bib0290","first-page":"1307","article-title":"The value of gynecologic cancer follow-up: evidence based ignorance?","volume":"20","author":"Lajer","year":"2010","journal-title":"Int J Gynecol Cancer"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517300258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517300258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:00:53Z","timestamp":1779807653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517300258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":58,"alternative-id":["S0301211517300258"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.025","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The future for follow-up of gynaecological cancer in Europe. Summary of available data and overview of ongoing trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}